CSIMarket
 
Charles River Laboratories International inc   (CRL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Charles River Laboratories International Inc Income Statement Quarterly

CRL


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Dec 30 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jul 01 2023)
II. Quarter
(Apr 01 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 1,026.62 1,059.94 1,029.37
Revenue From Contract With Customer Excluding Assessed Tax - - -
Service Revenue - - -
Product Revenue - - -
Total Revenue 1,013.48 1,026.62 1,059.94 1,029.37 1,099.84
Cost of Goods and Services Sold 564.85 587.56 578.10 565.48 603.13
Gross Profit 448.63 439.06 481.84 463.90 496.72
Selling, Administration, Marketing 197.14 176.11 199.76 174.85 199.64
Depriciation & Amortization 34.02 34.23 34.27 34.92 35.43
Research & development - - - - -
Asset Impairment Charges - - - - -
Other operatinig exp. /-income 84.54 77.22 82.86 86.24 97.83
Unusual Expense /-Income - - - - -
Total operating costs including COS 880.55 875.12 894.99 861.48 936.03
Operating income/-loss 132.92 151.50 164.95 167.89 163.81
Other Deductions / - Income
Interest expense 33.54 33.74 35.04 34.38 34.78
Interest income - - - - -
Net interest expense/-income 33.54 33.74 35.04 34.38 34.78
Investment Income, Interest - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -109.33 4.89 1.24 2.47 -115.89
Total costs & expenses 804.77 913.75 931.27 898.33 854.92
Income /-loss before income taxes 208.71 112.87 128.66 131.04 244.92
Income taxes expenses/-benefit 19.75 24.85 29.22 27.09 55.82
Income after income taxes 188.95 88.02 99.44 103.95 189.11
Net income/-loss of other equity - - 0.00 - -
Income/-loss from cont. Ops. 188.95 88.02 99.44 103.95 189.11
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 188.95 88.02 99.44 103.95 189.11
Noncontrolling interests 1.87 0.63 2.42 0.82 -253.26
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 187.08 87.39 97.02 103.13 187.41
EBIT 242.25 146.62 163.71 165.42 279.70
EBITD 322.76 225.49 241.38 242.49 357.25
EBITDA 322.76 225.49 241.38 242.49 357.25


Per Share (GAAP Quarterly, in $) (Dec 30 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jul 01 2023)
II. Quarter
(Apr 01 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Basic EPS (excl. extra items) 3.65 1.70 1.89 2.02 3.68
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 3.65 1.70 1.89 2.02 3.68
Basic shares outstanding (Mill. of Units) 51.31 51.28 51.22 51.10 50.92
   EPS other shares - - - - -
Diluted Net EPS 3.62 1.69 1.89 2.01 3.67
Diluted average shares (Mill. of Units) 51.48 51.61 51.47 51.43 51.29
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com